HURA - NASDAQ

TuHURA Biosciences, Inc.

HURA·NASDAQ

$2.19

+5.8%

HealthcareBiotechnology

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$139.46M

EPS-0.6300

P/E Ratio-3.48

Earnings Date08/13/2026

hura

Other Current Liabilities

Last Annual Value

5.72M

3-Year CAGR

104%

5-Year CAGR

59%

10-Year CAGR

Adjust for Inflation

TuHURA Biosciences, Inc. Competitors Analysis of Other Current Liabilities

HURA · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
TuHURA Biosciences, Inc. NASDAQ:HURA	5.72M	246.9%	65.8%	67.4%
Cognition Therapeutics, Inc. NASDAQ:CGTX	11.99M	117.5%	37.1%	N/A
Seer, Inc. NASDAQ:SEER	7.16M	38.0%	8.7%	N/A
Context Therapeutics Inc. NASDAQ:CNTX	5.38M	101.1%	128.9%	N/A
Ovid Therapeutics Inc. NASDAQ:OVID	0.00	N/A	N/A	N/A
Armata Pharmaceuticals, Inc. AMEX:ARMP	3.46M	38.9%	N/A	15.4%
Inovio Pharmaceuticals, Inc. NASDAQ:INO	36.44M	54.2%	12.0%	16.2%
Seres Therapeutics, Inc. NASDAQ:MCRB	4.57M	-57.4%	-26.4%	N/A
Agenus Inc. NASDAQ:AGEN	83.11M	-16.2%	1.9%	29.3%
Acumen Pharmaceuticals, Inc. NASDAQ:ABOS	20.54M	73.9%	47.3%	N/A
VistaGen Therapeutics, Inc. NASDAQ:VTGN	3.36M	115.2%	N/A	N/A

TuHURA Biosciences, Inc. Fair Value Envelope

HURA · NASDAQ

Our analysis suggests that HURA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.19, this represents a potential HIDDEN relative to our calculated worth for TuHURA Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $2.19

Related Guides

Blog Categories

Continue your HURA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.